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ABSTRACT 
Motivation: Coenzyme Q10 (CoQ10), or ubiquinone, has a crucial role in the energetic metabolism due to its redox capacity in 
the electron transport chain (ETC), where it shuttles electrons from complex I or II to complex III. Lack of this essential component 
leads to mitochondrial disorders characterized by a rare condition with a huge spectrum of different phenotypes and different 
genetic mutations. To date, specific genotype-phenotype correlations do not exist because the link between specific genetic 
defects and phenotypes is unclear. In this way, the diagnosis and treatment of this patients is so complicated. The diagnosis on 
time is extremely important to start the treatment in order to avoid the fulminant course of the disease with an irreversible damage 
and a fatal outcome. 
 
In a previous study reported in our lab it was described that CoQ10-deficient fibroblasts (independently from the etiology) showed 
a common transcriptomic profile. The expression of certain genes was modified in the same way, that it to say, they were always 
increased or decreased. COQ4 is one of the genes involved in CoQ10 biosynthesis. It has been also demonstrated that COQ4 
mutations are responsible for early-onset mitochondrial diseases with heterogeneous clinical presentations and associated with 
CoQ10 deficiency. The aim of this work is to find a possible correlation between different COQ4 mutations, the pathological 
phenotype, the clinical severity of the disease and the level of markers genes expression. 
 
Methods: To achieve this goal, we have used two fibroblast cell lines as control, and four mutant fibroblast cell lines from patients 
with different COQ4 mutations. We have performed different genetic and biochemical assays such as analysis of the expression 
profile by microarray, Seahorse or flow cytometry. 
 
Results: Fibroblasts from subjects with COQ4 mutations show similar profiles between them, and at the same time, they show 
a different profile when we compared them to control fibroblasts. In adittion, a more differentiated profile is observed according 
as the severity of the symptoms increases. Taken together, these results suggest a correlation between the phenotype and the 
clinical severity. 
 
Conclusions: Cells with COQ4 mutations look for an adaptative biological response to face the mithocondrial damage due to 
the CoQ10 deficiency. And interestingly, our results suggest an association between genothype and phenotype in these patients. 
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